October 19, 2022 M&A, Partnerships

GE Healthcare and AMC Health to Partner in Remote Patient Monitoring to Provide Patients with Chronic and Post-Acute Care in the Home

Chicago and New York – October 19, 2022 – GE Healthcare and AMC Health today announced a collaboration that allows clinicians to offer Remote Patient Monitoring (RPM) as a virtual care solution that extends patient care outside the hospital to the home environment. The combination of GE Healthcare’s acute patient monitoring capabilities in the hospital... Read more

October 16, 2022 Atomic Spectroscopy Clinical Research/Diagn. Licensing, IP, and Legal M&A, Partnerships

Telix Partnership Expands GE Healthcare Immuno-Diagnostics Offering to the Global Clinical Research Market

New agreement adds two Telix investigational PET imaging radiotracers to GE Healthcare’s immuno-diagnostic portfolio, to enable patient selection and monitoring in immunotherapy trials Telix tracers evaluate levels of carbonic anhydrase IX and lactate in tumours to inform and improve therapy selection GE Healthcare’s Pharmaceutical Diagnostics business is an established global supplier of PET imaging tracers... Read more

October 16, 2022 Clinical Research/Diagn. Microscopy

GE Healthcare Introduces Omni Legend: A First-of-its-Kind All-Digital PET/CT System to Drive Efficiency, Enhance Diagnostics, and Deliver on Precision Medicine

Chicago, U.S. and Barcelona, Spain – October 16, 2022 – At the European Association of Nuclear Medicine (EANM) Annual Meeting, GE Healthcare proudly introduces Omni Legend[i], the first system on its all-new, all-digital PET/CT platform. This cutting-edge system features a brand-new category of digital BGO (dBGO) detector material with a small crystal size that delivers... Read more